SE0402635D0 - Chemical compounds - Google Patents

Chemical compounds

Info

Publication number
SE0402635D0
SE0402635D0 SE0402635A SE0402635A SE0402635D0 SE 0402635 D0 SE0402635 D0 SE 0402635D0 SE 0402635 A SE0402635 A SE 0402635A SE 0402635 A SE0402635 A SE 0402635A SE 0402635 D0 SE0402635 D0 SE 0402635D0
Authority
SE
Sweden
Prior art keywords
chemical compounds
compositions
preparing
processes
compound
Prior art date
Application number
SE0402635A
Other languages
English (en)
Inventor
Krister Henriksson
Matti Lepistoe
Vijaykumar Hulikal
Haakan Bladh
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Priority to SE0402635A priority Critical patent/SE0402635D0/sv
Publication of SE0402635D0 publication Critical patent/SE0402635D0/sv
Priority to US11/718,203 priority patent/US20110130426A1/en
Priority to EP05797057A priority patent/EP1807405A1/en
Priority to CNA2005800375054A priority patent/CN101052627A/zh
Priority to RU2007115548/04A priority patent/RU2007115548A/ru
Priority to RSP-2007/0077A priority patent/RS20070077A/sr
Priority to MX2007004861A priority patent/MX2007004861A/es
Priority to BRPI0517259-4A priority patent/BRPI0517259A/pt
Priority to PCT/SE2005/001608 priority patent/WO2006046914A1/en
Priority to KR1020077009608A priority patent/KR20070072550A/ko
Priority to CA002584409A priority patent/CA2584409A1/en
Priority to AU2005300148A priority patent/AU2005300148A1/en
Priority to ARP050104506A priority patent/AR051471A1/es
Priority to GT200500306A priority patent/GT200500306A/es
Priority to PA20058651101A priority patent/PA8651101A1/es
Priority to UY29181A priority patent/UY29181A1/es
Priority to PE2005001261A priority patent/PE20060931A1/es
Priority to TW094137740A priority patent/TW200630352A/zh
Priority to EC2007007323A priority patent/ECSP077323A/es
Priority to IL182424A priority patent/IL182424A0/en
Priority to ZA200703389A priority patent/ZA200703389B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36Radicals substituted by singly-bound nitrogen atoms
    • C07D213/42Radicals substituted by singly-bound nitrogen atoms having hetero atoms attached to the substituent nitrogen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D261/00Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/08Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/20Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30Hetero atoms other than halogen
    • C07D333/34Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/10Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
SE0402635A 2004-10-29 2004-10-29 Chemical compounds SE0402635D0 (sv)

Priority Applications (21)

Application Number Priority Date Filing Date Title
SE0402635A SE0402635D0 (sv) 2004-10-29 2004-10-29 Chemical compounds
AU2005300148A AU2005300148A1 (en) 2004-10-29 2005-10-26 Novel sulphonamide derivatives as glucocorticoid receptor modulators for the treatment of inflammatory diseases
PCT/SE2005/001608 WO2006046914A1 (en) 2004-10-29 2005-10-26 Novel sulphonamide derivatives as glucocorticoid receptor modulators for the treatment of inflammatory diseases
CA002584409A CA2584409A1 (en) 2004-10-29 2005-10-26 Novel sulphonamide derivatives as glucocorticoid receptor modulators for the treatment of inflammatory diseases
CNA2005800375054A CN101052627A (zh) 2004-10-29 2005-10-26 作为糖皮质激素受体调节剂用于治疗炎性疾病的新磺酰胺衍生物
RU2007115548/04A RU2007115548A (ru) 2004-10-29 2005-10-26 Новые сульфонамидные производные в качестве модуляторов глюкокортикоидного рецептора для лечения воспалительных заболеваний
RSP-2007/0077A RS20070077A (en) 2004-10-29 2005-10-26 Novel sulphonamide derivatives as glucocorticoid receptor modulators for the treatment of inflamatory diseases
MX2007004861A MX2007004861A (es) 2004-10-29 2005-10-26 Derivados de sulfonamida novedosos como moduladores de receptor glucocorticoide para el tratamiento de enfermedades inflamatorias.
BRPI0517259-4A BRPI0517259A (pt) 2004-10-29 2005-10-26 novos derivados de sulfonamida como moduladores do receptor de glicocorticóide para o tratamento de doenças inflamatórias
US11/718,203 US20110130426A1 (en) 2004-10-29 2005-10-26 Novel Sulphonamide Derivatives as Glucocorticoid Receptor Modulators for the Treatment of Inflammatory Diseases
KR1020077009608A KR20070072550A (ko) 2004-10-29 2005-10-26 염증 질환의 치료를 위한 글루코코르티코이드 수용체조절제로서의 신규 술폰아미드 유도체
EP05797057A EP1807405A1 (en) 2004-10-29 2005-10-26 Novel sulphonamide derivatives as glucocorticoid receptor modulators for the treatment of inflammatory diseases
GT200500306A GT200500306A (es) 2004-10-29 2005-10-27 Compuestos quimicos
ARP050104506A AR051471A1 (es) 2004-10-29 2005-10-27 Derivados de sulfonamida como moduladores del receptor de glugocorticoides
PA20058651101A PA8651101A1 (es) 2004-10-29 2005-10-28 Compuestos quimicos
UY29181A UY29181A1 (es) 2004-10-29 2005-10-28 Derivados de bencenosulfonamidas n-sustituidos, composiciones que los contienen, procesos de preparación y aplicaciones
PE2005001261A PE20060931A1 (es) 2004-10-29 2005-10-28 Derivados de sulfonamida como moduladores de los receptores de glucocorticoides (gr)
TW094137740A TW200630352A (en) 2004-10-29 2005-10-28 Chemical compounds
EC2007007323A ECSP077323A (es) 2004-10-29 2007-03-14 Nuevos derivados de sulfonamida como moduladores del receptor de glucocorticoides para el tratamiento de enfermedades inflamatorias
IL182424A IL182424A0 (en) 2004-10-29 2007-04-10 Novel sulphonamide derivatives as glucocorticoid receptor modulators for the treatment of inflammatory diseases
ZA200703389A ZA200703389B (en) 2004-10-29 2007-04-25 Novel sulphonamide derivatives as glucocorticoid receptor modulators for the treatment of inflammatory diseases

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0402635A SE0402635D0 (sv) 2004-10-29 2004-10-29 Chemical compounds

Publications (1)

Publication Number Publication Date
SE0402635D0 true SE0402635D0 (sv) 2004-10-29

Family

ID=33448752

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0402635A SE0402635D0 (sv) 2004-10-29 2004-10-29 Chemical compounds

Country Status (21)

Country Link
US (1) US20110130426A1 (sv)
EP (1) EP1807405A1 (sv)
KR (1) KR20070072550A (sv)
CN (1) CN101052627A (sv)
AR (1) AR051471A1 (sv)
AU (1) AU2005300148A1 (sv)
BR (1) BRPI0517259A (sv)
CA (1) CA2584409A1 (sv)
EC (1) ECSP077323A (sv)
GT (1) GT200500306A (sv)
IL (1) IL182424A0 (sv)
MX (1) MX2007004861A (sv)
PA (1) PA8651101A1 (sv)
PE (1) PE20060931A1 (sv)
RS (1) RS20070077A (sv)
RU (1) RU2007115548A (sv)
SE (1) SE0402635D0 (sv)
TW (1) TW200630352A (sv)
UY (1) UY29181A1 (sv)
WO (1) WO2006046914A1 (sv)
ZA (1) ZA200703389B (sv)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200800150A (en) 2005-12-21 2008-01-01 Organon Nv Compounds with medicinal effects due to interaction with the glucocorticoid receptor
TW200829578A (en) 2006-11-23 2008-07-16 Astrazeneca Ab Chemical compounds 537
JO2754B1 (en) 2006-12-21 2014-03-15 استرازينكا ايه بي Amylendazoleil derivatives for the treatment of glucocorticoid-mediated disorders
EP2428504B1 (en) * 2008-04-14 2017-05-17 The Board of Regents of the University of Texas System Small molecule inhibitors of the pleckstrin homology domain and method for using same
TWI445705B (zh) 2008-05-20 2014-07-21 Astrazeneca Ab 經苯基及苯并二基取代之吲唑衍生物
AR072297A1 (es) 2008-06-27 2010-08-18 Novartis Ag Derivados de indol-2-il-piridin-3-ilo, composicion farmaceutica que los comprende y su uso en medicamentos para el tratamiento de enfermedades mediadas por la sintasa aldosterona.
PL3263564T3 (pl) 2012-02-29 2020-11-16 Chemocentryx, Inc. 1h-pirazol-1-ilo benzenosulfonamidy aza-arylowe jako antagoniści ccr(9)
MX2015007608A (es) 2012-12-14 2016-04-13 Phusis Therapeutics Inc Metodos y composiciones para inhibir cnksr1.
KR20240033093A (ko) 2014-10-06 2024-03-12 케모센트릭스, 인크. C-c 케모카인 수용체 타입 9 (ccr9)의 억제제 및 항-알파4베타7 인테그린 차단 항체의 조합 요법
US10227317B2 (en) 2015-02-25 2019-03-12 Lupin Limited Process for the preparation of vortioxetine
WO2016172191A1 (en) 2015-04-20 2016-10-27 Phusis Therapeutics, Inc. Compounds, compositions and methods for inhibiting cnksr1
UA127357C2 (uk) 2018-04-18 2023-07-26 Констеллатіон Фармацеутікалс, Інк. Модулятори метилмодифікуючих ферментів, композиції та їх використання
US11919912B2 (en) 2018-05-21 2024-03-05 Constellation Pharmaceuticals, Inc. Modulators of methyl modifying enzymes, compositions and uses thereof
US10792360B1 (en) 2019-11-21 2020-10-06 Chemocentryx, Inc. Compositions and methods for treating inflammatory bowel disease using CCR9 inhibitor and anti-TNF-alpha blocking antibodies

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US444347A (en) * 1891-01-06 James
US3992441A (en) * 1972-12-26 1976-11-16 Pfizer Inc. Sulfamylbenzoic acids
DE3535167A1 (de) * 1985-10-02 1987-04-09 Boehringer Mannheim Gmbh Neue sulfonyl-phenyl(alkyl)amine, verfahren zu ihrer herstellung sowie arzneimittel
DE3632329A1 (de) * 1986-09-24 1988-03-31 Bayer Ag Substituierte phenylsulfonamide
GB9504854D0 (en) * 1994-03-31 1995-04-26 Zeneca Ltd Nitrogen derivatives
US5545669A (en) * 1994-06-02 1996-08-13 Adams; Jerry L. Anti-inflammatory compounds
AU5772296A (en) * 1995-05-19 1996-11-29 Chiroscience Limited 3,4-disubstituted-phenylsulphonamides and their therapeutic use
TW523506B (en) * 1996-12-18 2003-03-11 Ono Pharmaceutical Co Sulfonamide or carbamide derivatives and drugs containing the same as active ingredients
JP4253126B2 (ja) * 1998-01-29 2009-04-08 アムジェン インコーポレイテッド Ppar−ガンマ調節剤
US6569885B1 (en) * 1999-12-23 2003-05-27 Icos Corporation Cyclic AMP-specific phosphodiesterase inhibitors
EP1432693A2 (en) * 2001-10-01 2004-06-30 Taisho Pharmaceutical Co. Ltd. Mch receptor antagonists
AU2003248549B2 (en) * 2002-05-24 2010-04-08 Millennium Pharmaceuticals, Inc. CCR9 inhibitors and methods of use thereof
JP5008025B2 (ja) * 2003-02-20 2012-08-22 エンサイシブ・ファーマシューティカルズ・インコーポレイテッド フェニレンジアミンウロテンシン−ii受容体拮抗薬およびccr−9拮抗薬
US7393873B2 (en) * 2003-07-02 2008-07-01 Merck & Co., Inc. Arylsulfonamide derivatives
US20050250820A1 (en) * 2004-03-08 2005-11-10 Amgen Inc. Therapeutic modulation of PPARgamma activity

Also Published As

Publication number Publication date
AU2005300148A1 (en) 2006-05-04
IL182424A0 (en) 2007-07-24
ECSP077323A (es) 2007-04-26
US20110130426A1 (en) 2011-06-02
CN101052627A (zh) 2007-10-10
BRPI0517259A (pt) 2008-10-07
MX2007004861A (es) 2007-05-09
RS20070077A (en) 2008-09-29
PA8651101A1 (es) 2006-06-02
TW200630352A (en) 2006-09-01
RU2007115548A (ru) 2008-12-10
GT200500306A (es) 2006-06-06
EP1807405A1 (en) 2007-07-18
PE20060931A1 (es) 2006-10-13
AR051471A1 (es) 2007-01-17
UY29181A1 (es) 2006-05-31
WO2006046914A1 (en) 2006-05-04
KR20070072550A (ko) 2007-07-04
ZA200703389B (en) 2009-12-30
CA2584409A1 (en) 2006-05-04

Similar Documents

Publication Publication Date Title
TW200630326A (en) Chemical compounds
TW200630352A (en) Chemical compounds
UY29875A1 (es) Compuestos quimicos
TW200610761A (en) Chemical compounds
MX2009011997A (es) Derivados de pirrolopirimidin-7-ona y su uso como farmaceuticos.
UY30736A1 (es) Compuestos quimicos 537
SE0401345D0 (sv) Therapeutic compounds: Pyridine as scaffold
SE0402762D0 (sv) Indazole sulphonamide derivatives
SE0401762D0 (sv) Novel compounds
MX2010001574A (es) Ligandos del receptor cannabinoide.
SE0401342D0 (sv) Therapeutic compounds
SE0302573D0 (sv) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
TW200610759A (en) Chemical compounds
SE0301701D0 (sv) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
TW200626581A (en) Compounds, compositions containing them, preparation thereof and uses thereof
SE0301320D0 (sv) Positive modulators of nicotinic acetylcholine receptors
SE0103819D0 (sv) Chemical compounds
UA83832C2 (ru) Производные бензимидазола, фармацевтическая композиция, которая их содержит, способ их получения и их применение
SE0302570D0 (sv) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
SE0401763D0 (sv) Compounds
SE0301369D0 (sv) Chemical compounds
SE0302572D0 (sv) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
SE0401656D0 (sv) Chemical compounds
SE0203820D0 (sv) chemical compounds
SE0402636D0 (sv) Chemical compounds